The smart ring maker’s SEC filing follows a $75m investment from Dexcom to integrate glucose monitoring with wellness data.
ŌURA has submitted confidential paperwork to the SEC for a proposed IPO, though share count and pricing remain undisclosed. The company stated the offering will proceed after SEC review, contingent on market conditions.
The filing follows a $75m investment from Dexcom in November 2024, aimed at integrating continuous glucose monitoring with ŌURA’s sleep and cardiovascular metrics. Partnerships with femtech firm Mira and others have expanded its medtech alliances.
No timeline for the IPO was provided, with ŌURA citing dependence on regulatory and market factors.